Figure 1. Experimental design outline. A: Animals received bilateral (oculus uterque/OU) subconjunctival injections of triamcinolone acetonide (TA) and were treated with Adenoviral vectors – AdPLAT, AdPLATNE, or AdNull – in the right eye (oculus dexter/OD) and control balanced salt solution (BSS) in the left eye (oculus sinister/OS). B and C: Animals were treated with intravitreal protein (tPA or NE-tPA) injections in the right eye (OD) and control bovine serum albumin (BSA) in the left eye (OS). Naïve C57BL/6J animals were also used for comparison purposes.